Fundraising Fox
Pierre Beauparlant
InvestorVenture Partner at Sanderling Ventures
Find your path to Pierre
10 people in our graph can introduce you to Pierre.
Sign up to see every warm intro you have to Pierre
- Paths you didn't know you had: your email and LinkedIn already hold routes to Pierre. We find them
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes you can't see from your own inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
About
Beauparlant, a Ph.D. with over 25 years in large pharma and venture-backed biopharma from discovery to commercialization, has served as CEO of Sanderling portfolio companies including PreciThera and SpecificiT Pharma.
Colleagues at Sanderling Ventures
Benjamin F. McGraw III
Venture Partner at Sanderling Ventures
Fred Middleton
Managing Director at Sanderling Ventures
Michael Dixon
Principal at Sanderling Ventures
Paulette Taylor
General Counsel & Principal at Sanderling Ventures
Peter McWilliams
Venture Partner at Sanderling Ventures
Timothy Mills
Managing Director at Sanderling Ventures
Frequently asked questions
- Who is Pierre Beauparlant?
- Beauparlant, a Ph.D. with over 25 years in large pharma and venture-backed biopharma from discovery to commercialization, has served as CEO of Sanderling portfolio companies including PreciThera and SpecificiT Pharma.
- Where does Pierre Beauparlant work?
- Pierre Beauparlant is Venture Partner at Sanderling Ventures.